Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma

NCT01975519 is registered in ClinicalTrials.gov with Tracon Pharmaceuticals Inc. as lead sponsor.

NCT NCT01975519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01975519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma
Lead sponsor
Tracon Pharmaceuticals Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
December 10, 2013
Completion date
March 11, 2019
Enrollment
111 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

advanced soft tissue sarcoma